The FDA estimates that up to 40% of pharmaceuticals shipped from Argentina, Colombia, and Mexico may be counterfeit.
The FDA estimates that up to 40% of pharmaceuticals shipped from Argentina, Colombia, and Mexico may be counterfeit.